News Report

ICMR Okays Use Of Hydroxychloroquine For High Risk COVID 19 Patients With Caution

The Indian Council of Medical Research has recommended the use of anti-malarial drug Hydroxychloroquine “under exceptional circumstances” as a line of treatment against high-risk Covid-19 patients.
The recommendation comes amid a global debate on whether the anti-malarial drug will prove effective in treating Covid-19 and also after anti-HIV drugs were used as a treatment on patients admitted for Covid-19 in Jaipur, as well as in a few cases abroad. #Hydroxychloroquine #ICMR #COVID19

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts